ZINNAT 125mg/5mls | CEFUROXIME GSK – 50mls
Cefuroxime is a second-generation cephalosporin antibacterial used in the treatment of susceptible infections. These have included bronchitis (and other lower respiratory-tract infections), bone and joint infections, gonorrhoea, otitis media, peritonitis, pharyngitis, sinusitis, meningitis (although treatment failures have been reported in H. influenzae meningitis), skin infections (including soft-tissue infections), and urinary-tract infections. It is also used for surgical infection prophylaxis.
Gastrointestinal disturbances, including diarrhoea, nausea, and vomiting, have occurred in some patients receiving ZINNAT in Kenya. There have been rare reports of Stevens-Johnson syndrome, erythema multiforme, and toxic epidermal necrolysis. Mild to moderate hearing loss has been reported in some children given higher doses of ZINNAT for the treatment of meningitis.